Checked
Ardelyx, Inc.
Nasdaq: ARDX · Pharmaceutical Preparations · Fremont, CA
- Revenue
- $407.3M
- +22.1% vs. prior year
- Net income
- -$61.6M
- -15.1% net margin
- Total assets
- $501.6M
- Diluted EPS
- -$0.26
Company details
As reported to the SEC
- SEC CIK
- 1437402
- Stock
- Nasdaq: ARDX
- Legal Entity Identifier (LEI)
- 549300F542QR4SXHCY32
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- Headquarters
- 34175 Ardenwood Blvd., Fremont, CA 94555
- Incorporated in
- Delaware
- Fiscal year end (SEC record)
- December 31
- Filer status
- Large accelerated filer
- Phone
- (510) 745-7047
- Last annual report
- 02/19/2026
- Last quarterly report
- 08/06/2026
Formerly: NTERYX INC (until 06/09/2008)
Annual financials
U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.
| Fiscal year ended | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 |
|---|---|---|---|---|---|
| Revenue | $407.3M | $333.6M | $124.5M | $52.16M | $10.1M |
| Operating income | -$40.98M | -$27.95M | -$63.28M | -$63.76M | -$154.3M |
| Net income | -$61.6M | -$39.14M | -$66.07M | -$67.21M | -$158.2M |
| Diluted earnings per share | -$0.26 | -$0.17 | -$0.30 | -$0.42 | -$1.52 |
| Research and development | $71.53M | $52.32M | $35.54M | $35.2M | $91.14M |
| Total assets | $501.6M | $435.8M | $297.6M | $190.1M | $149.9M |
| Total liabilities | $334.7M | $262.5M | $130.8M | $91.74M | $67.3M |
| Shareholders' equity | $166.9M | $173.3M | $166.8M | $98.33M | $82.62M |
| Cash and cash equivalents | $68M | $64.93M | $21.47M | $96.14M | $72.43M |
| Long-term debt | $202.8M | $150.9M | $49.82M | $26.71M | $32.26M |
| Cash from operations | -$42.48M | -$44.81M | -$89.72M | -$70.04M | -$152.6M |
| Capital expenditures | $1.49M | $1.01M | $344K | $55K | $1.87M |
Federal and state records filed under the name Ardelyx, Inc.
Matched by the company name and by the subsidiary names it lists in SEC filings and other public records, after removing endings like Inc., Corp. and Holdings. Records marked Subsidiary were filed under a subsidiary name. A subsidiary that is not listed in those records is not included, and an unrelated business with the same name can appear.
Work visa sponsorship
Certified H-1B and PERM green card filings with the Department of Labor
| Employer on filing | H-1B | PERM |
|---|---|---|
| Ardelyx, Inc.Waltham, MA | 2 | 0 |
Recent filings
124 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
94 insider ownership reports (Forms 3, 4, 5 and 144) were filed about Ardelyx, Inc. in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other pharmaceutical preparations
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Johnson & JohnsonJNJ | New Brunswick, NJ | $94.19B | $26.8B |
| Eli Lilly & CoLLY | Indianapolis, IN | $65.18B | $20.64B |
| Merck & Co., Inc.MRK | Rahway, NJ | $65.01B | $18.25B |
| Pfizer IncPFE | New York, NY | $62.58B | $7.77B |
| AbbVie Inc.ABBV | North Chicago, IL | $61.16B | $4.23B |
| Astrazeneca PLCAZN | Cambridge, United Kingdom | $58.74B | $10.22B |
| Bristol Myers Squibb CoBMY | Princeton, NJ | $48.19B | $7.05B |
| Abbott LaboratoriesABT | Abbott Park, IL | $44.33B | $6.52B |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is Ardelyx, Inc.'s CIK number?
- Ardelyx, Inc.'s SEC Central Index Key (CIK) is 1437402.
- What is Ardelyx, Inc.'s stock ticker?
- Ardelyx, Inc. trades as Nasdaq: ARDX.
- What was Ardelyx, Inc.'s revenue?
- Ardelyx, Inc. reported revenue of $407.3M for the fiscal year ended Dec 31, 2025, +22.1% from the year before.
- When does Ardelyx, Inc.'s fiscal year end?
- Ardelyx, Inc.'s fiscal year end on file with the SEC is December 31; its most recent fiscal year ended Dec 31, 2025.
- Where is Ardelyx, Inc. headquartered?
- Ardelyx, Inc.'s principal executive office on file with the SEC is in Fremont, CA.
- Does Ardelyx, Inc. sponsor H-1B visas?
- Department of Labor records show 2 certified H-1B filings and 0 certified PERM filings under the name Ardelyx, Inc.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026